Cargando…
Rates of clinically apparent heparin-induced thrombocytopenia for unfractionated heparin vs. low molecular weight heparin in non-surgical patients are low and similar
With the growing use of low-molecular-weight heparins (LMWH) for the treatment and prevention of venous thromboembolism (VTE), it is important to provide an evidence-based comparison with unfractionated heparin (UFH) concerning rates of heparin-induced thrombocytopenia (HIT). Such comparisons are es...
Autores principales: | Locke, Charles FS, Dooley, John, Gerber, Jonathan |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1087886/ https://www.ncbi.nlm.nih.gov/pubmed/15807892 http://dx.doi.org/10.1186/1477-9560-3-4 |
Ejemplares similares
-
Unfractionated and low molecular weight heparin
por: Lima, Marcelo, et al.
Publicado: (2014) -
Low-Molecular-Weight Heparin and Unfractionated Heparin Decrease Th-1, 2, and 17 Expressions
por: Huang, Jing-Ning, et al.
Publicado: (2014) -
Low-molecular-weight heparin compared with unfractionated heparin in critically ill COVID-19 patients
por: Volteas, Panagiotis, et al.
Publicado: (2022) -
The efficacy and safety of low-molecular-weight heparin and unfractionated heparin in the treatment of cerebral venous sinus thrombosis
por: Afshari, Daryoush, et al.
Publicado: (2015) -
Heparin/low molecular weight heparins: Thrombocytopenia: 7 case reports
Publicado: (2021)